Literature DB >> 24720467

Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case-control study and meta-analysis.

Fa-Juan Cheng1, Xu-Jie Zhou, Yan-Feng Zhao, Ming-Hui Zhao, Hong Zhang.   

Abstract

OBJECTIVES: Recent animal experiments showed that CCR5-deficient lupus mice (CCR5(-/-)) were closely associated with aggravated lupus nephritis. CCR5 Δ32 variation, a nonsynonymous mutation of CCR5, resulted in altered CCR5 function. However, the CCR5 Δ32 mutation in human lupus nephritis has been rarely reported in the literature.
METHODS: A large case-control study that included 2010 samples from a Chinese population was conducted, followed by a meta-analysis combining the current and previously published studies to explore the effect of CCR5 Δ32 on lupus nephritis susceptibility.
RESULTS: Four CCR5 Δ32 heterozygote carriers were detected in lupus nephritis patients only. We detected no CCR5 Δ32 homozygotes in our study population. In the meta-analysis, including 1,092 cases and 2,229 controls, we found great heterogeneity between studies (p < 0.001, I(2)( )= 89.6%). Furthermore, stratified and sensitivity analyses suggested that ethnicity and CCR5 Δ32 allele frequency were the main origin of heterogeneity. In the subgroups without obvious heterogeneity, we observed a positive correlation between CCR5 Δ32 and lupus nephritis risk (p < 0.05).
CONCLUSIONS: Our study confirmed that the CCR5 Δ32 mutation is a very rare variation found in the Chinese population with Han ethnicity. However, CCR5 Δ32 might play a role in lupus nephritis susceptibility. Future replications and functional studies are needed.

Entities:  

Keywords:  Chinese Han ethnicity; complex autoimmune disease; functional genetic variant; susceptibility; systemic lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 24720467     DOI: 10.3109/08916934.2014.906581

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

Review 1.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

2.  CXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimoto's Thyroiditis Obtained by Fine Needle Aspiration Biopsy.

Authors:  Jan Jiskra; Marie Antošová; Jan Krátký; Hana Vítková; Zdeňka Límanová; Helena Marečková; Eliška Potluková
Journal:  J Immunol Res       Date:  2016-10-31       Impact factor: 4.818

3.  Prevention of CaCl2-induced aortic inflammation and subsequent aneurysm formation by the CCL3-CCR5 axis.

Authors:  Yuko Ishida; Yumi Kuninaka; Mizuho Nosaka; Akihiko Kimura; Akira Taruya; Machi Furuta; Naofumi Mukaida; Toshikazu Kondo
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

4.  Association of CCR5Δ32 Deletion and Human Cytomegalovirus Infection With Colorectal Cancer in Tunisia.

Authors:  Hanen Chelbi; Refka Jelassi; Sarra Belfkih; Amor Ben Amor; Nasreddine Saidi; Hamza Ben Salah; Nabiha Mzoughi; Imen Ben Dhifallah; Nadia Boujelben; Radhia Ammi; Aida Bouratbine; Ines Zidi; Karim Aoun
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

Review 5.  CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.

Authors:  Bruna Kulmann-Leal; Joel Henrique Ellwanger; José Artur Bogo Chies
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.